Chiesi acquires new manufacturing site in Nerviano
Nerviano to reacquire rights on NMS-293 from Merck
Aviceda aims to raise $200M; Nerviano gets back rights to PARP1 inhibitor
Chiesi unveils €430M investment to revitalize Italian production site for inhaler, biologics manufacturing
Chiesi Announces Plans To Build New Manufacturing Plant In Italy
We Found Comfy Recliners That Are Actually Stylish
Nerviano Medical Sciences Announces Enhanced US Executive Team
Nerviano Medical Sciences, Italfarmaco Partner on Novel PDC
Nerviano Medical Sciences describes new CDK11A inhibitors
Celltrion/Abpro, Merck/Nerviano and more Unite against Cancer
Nerviano Medical Sciences and Italfarmaco Announce Licensing of Linker-Payload Technology to Develop and Commercialize a Novel Peptide-Drug Conjugate
Iktos and Nerviano Medical Sciences Announce AI Collaboration
Marina Gioia: the atomick clock for satellite navigation
Nerviano Medical Sciences presents new CDC7 inhibitors
Shanghai’s SARI Pays $359M for Italian Cancer Biopharma NMS
Nerviano Medical Sciences to Present Preliminary Phase 1 PARP1 selective inhibitor data at the 35th AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Merck KGaA teams up with Italian oncology group in PARP1 development deal
Nerviano Medical Sciences divulges new WRN inhibitors
Merck Enters Collaboration and Option to License Agreement with Nerviano Medical Sciences to Develop Next-Generation PARP1 Selective Inhibitor
SIMIS Srl Appoints Laurent Contaut as the New CEO of SIMIS, Part of NMS Group of Companies
Chillicothe Man Arrested for Assault on Peace Officer After Driving Drunk
EMA stops imports of sterile drugs from Lampugnani Farmaceutici plant
Merck pays $169M for selective PARP1 drug, stepping up challenge to AstraZeneca and Gilead
Italy's Chiesi invests €430M in facility for respiratory therapies
Artemis 1: a world-class success story that will put humans back on the Moon
Photocatalytic Radical Coupling of Organoborates with α-Halogenated Electron-Poor Olefins
Incyte vets, with phase 1 within reach, raise $102M for new biotech to create better PARP, PI3K drugs
Chiesi acquires Italian site as part of 430 million euros investment
PCM-075 Proves Safe as Treatment for Colon, Other Cancer Types, Phase 1 Trial Shows
(PDF) Thyroidectomy in dogs with thyroid tumors: Survival analysis in 144 cases (1994‐2018)
Hydrogen Atomic Clocks to Fly on Galileo Second Generation
Graffiti Artist Creates Intriguing Optical Illusions
Finmeccanica - Selex ES Infrared Search and Track system for the Gripen
Dean Merriman Obituary (1958 - 2018) - Chillicothe, OH - Chillicothe Gazette
Dual Specificity Protein Kinase TTK Inhibitor Market Generated
Infrared search and track (IRST) technology gives jet fighter aircraft stealthy vision
Novartis divulges new WRN inhibitors
Radar – the new frontier
Acid catalyzed halogen dance on deactivated pyrroles - Tutino - 2010 - Journal of Heterocyclic Chemistry
Licenziamenti Teva di Nerviano. Lavoratori in presidio bloccano il Sempione | Fedaiisf Federazione delle
Fighter aircraft IRST: equipping the military with stealth vision
Leonardo develops multi-aperture infrared system
Teva Italia. Preoccupazione dei sindacati | Fedaiisf Federazione delle Associazioni Italiane degli
Two families, one promise
(PDF) Correlation between fine-needle aspiration cytology and histopathology in the evaluation of cutaneous and subcutaneous masses from dogs and cats
Halloween Milan 2024: here are 16 things to do this year in and around the city